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Abstract
The degradation of L-ascorbate (AsA) and its primary oxidation products, L-dehydroascorbate (DHA) and 2,3-L-
diketogulonate (2,3-DKG) were studied under physiological conditions. Analysis determined that L-erythrulose (ERU) and
oxalate were the primary degradation products of ASA regardless of which compound was used as the starting material. The
identification of ERU was determined by proton decoupled 13C-nuclear magnetic resonance spectroscopy, and was
quantified by high performance liquid chromatography, and enzymatic analysis. The molar yield of ERU from 2,3-DKG at
pH 7.0 37‡C and limiting O2, was s 97%. This novel ketose product of AsA degradation, was additionally qualitatively
identified by gas-liquid chromatography, and by thin layer chromatography. ERU is an extremely reactive ketose, which
rapidly glycates and crosslinks proteins, and therefore may mediate the AsA-dependent modification of protein
(ascorbylation) seen in vitro, and also proposed to occur in vivo in human lens during diabetic and age-onset cataract
formation. ß 2000 Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
L-Ascorbate (AsA) serves as the primary water
soluble antioxidant in cells [1]. AsA preferentially
interacts with reactive oxygen species (ROS) gener-
ated during oxidative stress, thus protecting cell con-
stituents from oxidative damage [2]. Recent interest
in the potential toxicity of AsA [3^5] has focused
attention on the primary oxidation product produced
when AsA interacts with ROS, L-dehydroascorbate
(DHA). Unlike AsA, DHA is both unstable in the
absence of oxygen [6], and is a reactive electrophile,
which generates further reactive degradation prod-
ucts over time in solution [5]. These electrophilic
products react with nucleophiles on proteins, specif-
ically lysinyl and arginyl residues, resulting in struc-
turally deleterious, non-enzymatic modi¢cations of
proteins [7]. Tissues maintain a low concentration
of DHA due to its reduction back to ASA by gluta-
thione, both enzymatically and non-enzymatically
[8]. However, there is an equilibrium level of DHA
equivalent to V5% the AsA pool, which may rise
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after oxidative stress [9^11]. Increases in DHA deg-
radation have been hypothesized to be involved in
the etiology of a variety of diseases, including senile
cataract [12], aging [13], diabetes [14] and Alzheim-
er’s disease [15]. These diseases have all been associ-
ated with increases in ROS production and protein
glycation. Hypothetically, increased ROS production
in disease could lead to increased AsA oxidation, and
therefore increased DHA accumulation and degrada-
tion to glycation-active products. It is therefore im-
portant to determine the products of AsA non-enzy-
matic degradation, as they may mediate the
deleterious physiological e¡ects of DHA. Determina-
tion of the major non-enzymatic degradation prod-
uct(s) of ASA at physiological conditions will also
enhance the understanding of the catabolism of
AsA in general.
DHA rapidly hydrolyzes in solution at pH 7.0 to
L-diketogulonate (2,3-DKG) [6], which is very unsta-
ble and degrades further. Forty years after the ¢rst
investigation in this area, it has been variously re-
ported, that the non-enzymatic/catabolic degradation
pathway of AsA leads through 2,3-DKG to CO2 and
L-xylose [16], CO2 and L-xylosone [17], CO2, and L-
xylonate plus L-lyxonate [18^20], oxalate and L-thre-
onate [17,19], or oxalate and L-threose [21]. These
divergent reports have prevented consensus on, and
new investigations into, which degradation products
of 2,3-DKG are produced under physiological con-
ditions. Thus both the non-enzymatic and catabolic
fates of vitamin C in vivo still remain in dispute.
Recently 2,3-DKG concentrations have been shown
to rise in oxidatively stressed human erythrocytes in
vitro [22], and in the lens of rats placed under dia-
betic stress [23]. High lenticular rates of 2,3-DKG
degradation in rats were correlated with increased
cataract formation in vivo [24]. Importantly, the
half life of DHA in vivo may be as short as 2 min
[25] with rapid production of 2,3-DKG. However the
fate of 2,3-DKG was not determined in these studies.
Our interest in the ultimate degradation product(s)
responsible for the ascorbylation of lens proteins
led us to reinvestigate the AsA degradation path-
way. The in vitro fates of AsA and its oxidation
products DHA and 2,3-DKG, were followed in a
pH 7.0 bu¡er at 23 or 37‡C, and in human lens
extracts, using nuclear magnetic resonance (NMR)
spectroscopy.
2. Materials and methods
2.1. Materials
L-Ascorbate, L-dehydroascorbate, and L-erythru-
lose (97%) were purchased from Aldrich, Milwaukee,
WI. These were assayed for purity by 13C-NMR, and
were found to contain no detectable impurities. Ad-
ditionally commercial ERU was assayed by proton
NMR, further con¢rming its purity. L-[2-13C]AsA
and L-[3-13C]AsA were purchased from Omicron Bio-
chemicals, South Bend, IN and the white crystalline
acids (99% 13C) contained no impurities as deter-
mined by NMR, and melting point. NADH and sor-
bitol dehydrogenase (EC 1.1.1.14, from sheep liver)
were purchased from Sigma, St. Louis, MO, as were
all other reagents used in the analytical studies. Po-
tassium L-2,3-DKG was synthesized from AsA ex-
actly as described by [26], and L-xylosone was pre-
pared as reported in [27]. 3-Deoxyglucosone was
synthesized by the method as described in [28].
Thin layer plates (Silica Gel 60 F254, 5U20 mm)
were obtained from Alltech, Deer¢eld, IL.
2.2. Thin-layer chromatography
TLC was conducted on silica gel plates using the
following irrigants: butanol^acetic acid^water
(3:1:1, v/v, irrigant A) and acetonitrile^water^ace-
tone^acetic acid (80:15:5:6, v/v, irrigant B). Plates
were stained using 2% vanillin (in 5% H2SO4, 95%
ethanol; spray 1), or 0.93% aniline (free base)^1.66%
O-phthalic acid in wet butanol (90% n-butanol, 10%,
water; spray 2), and heated at 120‡C for 10^15 min
for development.
2.3. High performance liquid chromatography
HPLC was carried out using a Phenomenenx Re-
zex-RNM-carbohydrate column (in the Na form),
with dimensions of 300U7.8 mm. The run £ow rate
was 0.6 ml/min, with dH2O as the mobile phase.
Aliquots were taken from the reaction mixtures con-
taining 0.1^0.2 M DHA or 2,3-DKG in 0.2^0.4 M
phosphate bu¡er and diluted 1:4 with dH2O. To re-
move UV absorbing chromophores, 50 mg of acti-
vated carbon was added per ml of the mixture. Sam-
ples were then sterile ¢ltered through a 0.2-Wm sterile
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acrodisc (Gelman Sciences, Ann Arbor MI), yielding
a clear sample eluant. The injection volume for each
sample run was 250 Wl. The chromatogram was
monitored at 278 nm, using a Kratos spectro£ow
773 UV detector.
2.4. Gas-liquid chromatography
GLC was performed using a Varian 3400 instru-
ment in the split mode. Separations were done using
a 25-m Quadex 001-Ov-17 capillary column with an
i.d. 0.025 mm. Analysis of sugar derivatives was
done with a hold time of 2 min after injection, fol-
lowed by a 150^250‡C temperature gradient at 10‡C/
min. Reaction mixtures containing 2,3-DKG or sug-
ar standards were prepared for chromatography by
preparing the alditol acetate derivatives according to
the method described in [21].
2.5. Nuclear magnetic resonance spectroscopy
Proton decoupled 13C-NMR spectra were acquired
at 23 or 37‡C on 1 ml samples of DHA, or 2,3-DKG,
in potassium phosphate bu¡er, pH 7.0 prepared in
9:1, H2O:D2O. A Bruker DRX500 (13C-unlabeled
studies) or DRX300 (13C-labeled studies) spectrome-
ter were used to collect spectra. The acquisition pa-
rameters used were; sweep frequency 125.757 MHz;
pulse duration 8.24 Ws (90‡); interpulse delay 4.5 Ws;
and 1.0 Hz line broadening. The number of scans
and other data speci¢c to a particular experiment
are reported in the ¢gure legends. All samples were
run with 3-(trimethylsilyl)propionic-2,2,3,3-d4 acid,
sodium salt as the internal standard, with its signal
set at 0.00 ppm.
2.6. Ultraviolet spectroscopy
A solution of commercial ERU (97%) was pre-
pared quantitatively in dH2O and puri¢ed by
HPLC. The fraction containing the sugar was dried
at 4‡C. This was dissolved in phosphate bu¡er, pH
7.0, and the absorbency constants were determined
(V= 278 nm, AM = 30 L/M31 cm31) representing the n
to Z* transition characteristic for ketones. Quanti¢-
cation of ERU in the HPLC chromatograms was
done by relating the observed ERU peak area to a
standard curve of area vs. concentration, prepared
by chromatography of known amounts of commer-
cial ERU.
2.7. Sorbitol dehydrogenase assay
A commercial enzyme solution was prepared by
dissolving 2 mg of sorbitol dehydrogenase (6.3 U/
mg) in 2 ml of 0.2 M KPO4 bu¡er, pH 7.0, and
diluting with 8 ml of 1.25% BSA, prepared in the
same bu¡er. The enzyme prepared in this manner
was found to be stable for at least 1 week at 4‡C.
ERU was assayed within the range from 0.025^0.2 M
in 0.1 M phosphate bu¡er, pH 7.0, containing 13^15
Wl of the BSA/enzyme solution (or the amount of
enzyme needed to reduce 0.1 M D-fructose at a rate
of V0.6 vA340/min). NADH was added at a level of
375 WM, and vA340 followed for 1 min. Each assay
was carried out in duplicate. The Km for commercial
ERU reduction was 0.260 M ( þ 17.6 M), while Vmax
was 707 nmol ml31 min31 ( þ 3.2 nmol ml31 min31).
Kinetic parameters were determined according to
[29]. The kinetics of the HPLC puri¢ed product of
2,3-DKG, matched those determined with commer-
cial ERU to within experimental error.
2.8. Human lens homogenates
Human lenses were obtained from Missouri Lions
Eye Tissue Bank, and Human lens homogenates
(HLH) were prepared as previously described [30],
with 1 ml of bu¡er per lens. Donors were aged 30^
40 years, and the protein concentration of the homo-
genate was determined to be 25 mg/ml by the method
of Bradford [31] for kinetic studies. Homogenates
were prepared to 50 mg/ml for 13C-AsA studies,
were 500 Wl homogenate is V1 human lens. All
lens protein extracts were prepared in chelex-treated
phosphate bu¡er, pH 7.0, and sterile ¢ltered before
use. No homogenates were dialyzed.
2.9. Degradation incubations
Incubations of DHA and 2,3-DKG were routinely
carried out in phosphate bu¡ers pH 7.0 at 23 or
37‡C, and sterile ¢ltered before incubation or before
analysis by NMR, HPLC, GLC, or TLC. 5 mM 13C-
AsA (1 ml) was oxidized with ascorbate oxidase 20 U
in 0.2 M phosphate bu¡er, pH 7.0, for 15 min. The
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enzyme was the rapidly removed by ultracentrifuga-
tion, and 500 Wl of the labeled DHA diluted to 2.5
mM for NMR with 400 Wl dH2O and 100 Wl D2O.
Initial spectra showed only signals of DHA and 2,3-
DKG.
2.10. SDS-PAGE
Gel electrophoresis of proteins cross-linked by sug-
ars was conducted under reducing conditions as de-
scribed by Laemmli [32]. All sugars were at a con-
centration of 10 mM and were incubated with 6 mg/
ml calf lens proteins for 5 days at 37‡C, then diluted
and assayed for crosslinking by SDS-PAGE.
2.11. Kinetics and 13C-NMR studies in human lens
homogenates
The NADH-dependent reduction of ERU by HLH
(prepared as in Section 2.8 except in 0.05 M potas-
sium phosphate bu¡er, pH 7.0) was studied with
ERU and L-[3-13C]-DHA/DKG (prepared as in Sec-
tion 2.9) as starting materials. Assays of ERU were
done within the range from 2.5 to 50 mM. NADH
(0.425 mM) was preincubated for 2^3 min with 50 Wl
HLH, which had been diluted with 300 Wl of bu¡er.
All assays of ERU were done at a total volume of
1 ml and the decrease at A340 was followed after the
addition of ERU. Each data point was done in du-
plicate and kinetic parameters determined as in Sec-
tion 2.7, over the ¢rst 2 min. The Km for reduction of
ERU was 21.3 mM ( þ 2.5 mM), while Vmax was 66.2
nmol ml31 min31 ( þ 3.2 nmol ml31 min31). Studies
to determine the e¡ect of varying the NAD/NADH
ratio on ERU reduction were done similarly as in
determination of kinetic constants. However, at the
start [NADH] was 0.37 mM, while [NAD] was var-
ied from 0 to 1.5 mM. ERU was added to start the
reduction at 0.020 M for all assays. In the determi-
nation of the e¡ects of D-sorbitol on ERU reduction
both [NADH] 0.37 mM and [ERU] 0.15 mM were
the same in all assays, while [D-sorbitol] was varied
from 0 to 0.45 M.
NMR studies on the reduction of ERU by HLH,
were done using 0.5 ml of oxidized L-[3-13C]AsA pre-
pared as in Section 2.9. This was added to 0.5 ml of
HLH prepared as in Section 2.8. Therefore, in these
studies, 0.5 ml HLE is equivalent to V1 human lens.
3. Results
3.1. Oxalate and ERU are the products of 2,3-DKG
degradation
2,3-DKG degradation was followed continuously
by 13C-NMR over 40 h at 23‡C under essentially
anaerobic conditions (Fig. 1). The initial NMR spec-
trum of 2,3-DKG with C1^C6 resonances at 176.98,
97.87, 97.28, 77.05, 71.07 and 64.92 (Fig. 1a) corre-
sponded to the reported proton decoupled spectra
[33]. After 24 h, the 2,3-DKG signals had decreased
substantially and ¢ve new resonances appeared at
215.23, 176.01, 78.74, 68.74 and 65.80 ppm. (Fig.
1b). After 40 h of incubation, the degradation was
nearly complete (Fig. 1c) with the production an ap-
parent ¢ve carbon product in nearly quantitative
Fig. 1. 13C-NMR proton decoupled spectra showing the degra-
dation over time of 0.1 M 2,3-DKG in 0.2 M phosphate bu¡er,
pH 7.0, 23‡C. Each spectra was acquired with a minimum of
2000 scans at 0 h (a), after 24 h (b), after 40 h (c), and ¢nal
spectra of degradation showing products (d) at 48 h, and a
spike of D with an Vequal molar amount of ERU (e). Note
the increase in only the four signals corresponding to ERU.
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yields. The identi¢cation of two products, ERU with
four carbons at 215.23, 78.74, 68.74, and 65.80 ppm,
and oxalate with two carbons (one resonance), was
con¢rmed by spiking the NMR tube at the end of
the degradation (Fig. 1d) with ERU (Fig. 1e). A
similar spike with authentic oxalate con¢rmed the
peak at 176.01 ppm as oxalate (data not shown).
The production of ERU was also detected by TLC
(Table 1). This analysis agreed with the NMR re-
sults, showing that the 2,3-DKG degradation prod-
uct consistently migrated with the ERU standard in
two solvent systems. In irrigant A, ERU was clearly
separated from L-threose, a previously proposed
product. GLC analysis showed that both erythritol
and threitol were formed following NaBH4 reduction
of the 2,3-DKG degradation product (Table 2). Since
both alditols were produced by the reduction of the
product, the 2,3-DKG degradation product could
again be identi¢ed as ERU.
3.2. ERU is produced quantitatively from both DHA
and 2,3-DKG
The degradation of DHA was similarly followed
by 13C-NMR. As shown in Fig. 2, the rate pro¢le for
production of 2,3-DKG from DHA and that for the
sequential degradation of 2,3-DKG to ERU, were
obtained at pH 7.0 and 37‡C. ERU was still the ¢nal
product with DHA as the starting material, and was
detected after 1.5 h of the DHA incubation. To
quantify the yield of ERU from 2,3-DKG, we devel-
oped an HPLC method for its separation and detec-
tion. The chromatogram (Fig. 3) shows that the 2,3-
DKG degradation product eluted with authentic
ERU as con¢rmed by spiking the reaction with the
commercial compound. The product was quanti¢ed
by HPLC and UV-VIS spectroscopy (Fig. 4). The
ketose could be detected after only 1 h by this meth-
od. At the end of the 2,3-DKG incubation, the ke-
tose accounted for 63.5% of the initial molar amount
of 2,3-DKG, and the half-life (t1=2) of ERU under
these conditions (see inset) was determined to be
V32 h. Considering both the production of ketose
from 2,3-DKG and the t1=2 of the ketose, the molar
Fig. 2. Time course for the degradation of 0.2 M DHA in 0.4
M phosphate bu¡er, pH 7.0, 37‡C as determined by proton de-
coupled 13C-NMR. Spectra were gathered for 1 h (1962 scans)
sequentially over 10 h using a Brunker DRX500 spectrometer.
A ¢nal spectrum was acquired after 18 h. For each spectrum,
the intensity of the ^CH2OH signal of the various degradation
species (SCH2ÿOH) were plotted as the molar fraction percent of
the signal intensity of the internal standard 0.1 M ethylene gly-
col (Sethylene glycol). Data points were plotted with time as the
average of each sequential spectrum over 1 h (i.e. ¢rst spectrum
plotted at 0.5 h, second spectrum at 1.5 h).
Table 2
Retention times for major peaks from GLC chromatograms for
derivatized alditol acetates
Alditol acetates of: Retention time (min)
Erythritol 11.93
Threitol 12.13
Xylitol 15.83
Sorbitol 16.85
L-2,3-DKG degradation product 11.93, 12.14
Samples from alditol standards were modi¢ed to the alditol ace-
tates as described in [20]. Aliquots from a degradation of 0.2 M
L-2,3,-DKG in 0.4 M phosphate bu¡er, pH 7.0, 23‡C, were re-
duced with NaBH4 to alditol acetates before GLC analysis as
in [20].
Table 1
TLC of the proposed and actual L-2,3-DKG degradation prod-
ucts
Carbohydrate Rf Irrigant A Rf Irrigant B
L-Xylose 0.48 0.33
L-Xylosone 0.43 0.43
D-Erythrose 0.53 0.52
L-Threose 0.62 0.54
L-Erythrulose 0.52 0.52
L-2,3-DKG degradation product 0.52 0.52
Results of chromatograms with reported 2,3-DKG degradation
products, L-erythrulose standard, and the actual product from a
degradation of 0.2 M 2,3-DKG in 0.4 M phosphate bu¡er, pH
7.0, and 23‡C.
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Fig. 5. 13C-NMR spectrum showing the products of 0.2 M 2,3-DKG reacted with 0.2 M H2O2 in 0.4 M phosphate bu¡er for 2 h.
Spectrum obtained using a Brunker DRX500 spectrometer. The numbers indicate the four most intense resonances of the major prod-
uct of diketogulonate oxidation, which correspond exactly with those of an L-threonate standard previously run under the same condi-
tions. 1, 181.69 ppm; 2, 75.70 ppm; 3, 75.70 ppm; 4, 65.79 ppm.
Fig. 4. Production of ERU from 0.2 M DKG in 0.4 M phos-
phate bu¡er, pH 7.0, 37‡C over time as determined by HPLC-
UV. Inset shows the degradation of 0.1 M ERU over time in
0.2 M phosphate bu¡er under the same conditions. Quanti¢ca-
tion was determined by HPLC-UV followed at 278 nm.
Fig. 3. HPLC chromatogram of the degradation products of
0.2 M DHA in 0.4 M phosphate bu¡er, pH 7.0, 37‡C after 24
h. Top panel: the initial separation. Bottom panel: the same
sample with excess ERU added as a spike.
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percentage of 2,3-DKG which was generated as
ERU was estimated to be s 97%. An enzymatic as-
say using sorbitol dehydrogenase was performed on
the HPLC fraction containing the product. Since this
enzyme recognizes only the L-enantiomer of ERU
[34,35], the NADH-dependent reduction of the
HPLC eluant con¢rmed that it had retained the L-
stereochemical con¢guration of the progenitor mole-
cule L-2,3-DKG. Additionally, the kinetics of the en-
zymatic reduction of the 2,3-DKG product matched
those obtained with commercial ERU (see Section
2.7). The single predicted product L-threitol (data
Fig. 6. 13C-NMR spectra following the degradation of 2.5 mM 13C-labeled AsA in 50 mM chelex-treated 0.1 M phosphate bu¡er, pH
7.4, and 23‡C over 12 h. Spectra were acquired using a Brunker DRX300 spectrometer, with 2880 scans for each 2-h spectrum. Upper
panel shows near complete conversion of C-2 signal of 2,3-DKG to oxalate. Lower panel shows near complete conversion of C-3 sig-
nal of 2,3-DKG to ERU.
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not shown), also con¢rmed that the peak originally
contained solely ERU.
3.3. ERU is the product of AsA degradation under
non-oxidative conditions; L-threonic acid is
produced under oxidative conditions
We next tested whether ERU could be produced
from AsA. The degradation of L-[2-13C]AsA and L-
[3-13C]AsA were followed after oxidation with ascor-
bate oxidase, which produces the products DHA and
H2O from ascorbate and O2, in a chelex-treated
phosphate bu¡er, at 23‡C. The use of labeled AsA
allowed the analysis of the degradation pathway by
NMR at more physiological concentrations of AsA
oxidation products. The results seen in Fig. 5, clearly
show that the major products after 12 h, are oxalate
(Fig. 5, upper panel) from L-[2-13C]AsA. Concomi-
tantly ERU production (Fig. 5, lower panel) from L-
[3-13C]AsA is seen. In both cases the major signal
after 2 h is that of 2,3-DKG (13C-2, at 97.87 ppm,
13C-3 at 97.28 ppm), which rapidly and quantita-
tively became only the signal for oxalate at 176.01
ppm (upper panel), and the C-1 signal of ERU at
68.74 ppm (lower panel). In both spectra, unidenti-
¢ed intermediates can readily be detected. These re-
sults suggest that the mechanism by which oxalate
and ERU are produced is via a carbon^carbon
bond scission between C2, and C3 of 2,3-DKG, or
an intermediate produced from 2,3-DKG
Having established 2,3-DKG as the progenitor of
ERU, we questioned why this ketose had not been
found previously in AsA degradation studies, since it
was the only product seen in our studies. H2O2 (the
product of AsA oxidation) was incubated with 2,3-
DKG for 2 h (Fig. 6) in a phosphate bu¡er which
had not been treated with chelex. The resulting
NMR spectrum of the reaction clearly shows L-thre-
onate as the major product (numbers are shown
above the four signals of threonate), and a strong
HCO33 signal is also seen along with several uniden-
ti¢ed acid signals. In this experiment, no ERU was
detected. This suggest that H2O2 produced by AsA
oxidation, can oxidize 2,3-DKG preventing the for-
mation of ERU.
3.4. ERU crosslinks lens protein
We tested the protein crosslinking ability of ERU
to determine if it could account for the reported
AsA-dependent modi¢cation of protein [5]. As seen
in Fig. 7, ERU crosslinked bovine lens proteins to a
greater extent than the previously proposed glyc-
ation-active sugars glucose, fructose, or 3-deoxyglu-
cosone after 4 days of incubation. This was primarily
indicated by the large amount of high molecular
weight aggregates that did not enter the resolving gel.
3.5. Human lens e¡ectively reduces ERU to L-threitol
Since ERU production during AsA catabolism
would be potentially deleterious, we studied the ca-
pacity of HLH to reduce ERU to the tetritol. As
determined (see Section 2.11) lens contains V1.33
U of NADH-dependent activity towards ERU as a
substrate. The kinetic parameters were very similar
to those found for the reduction of ERU by puri¢ed
Fig. 7. SDS-PAGE showing the crosslinking of human lens pro-
teins by various sugars. Lanes 1 and 7, molecular weight stan-
dards; lane 2, no sugar; lane 3, glucose; lane 4, fructose; lane
5, 3-deoxyglucosone; and lane 6, ERU. The sugars (10 mM)
were incubated with 6 mg/ml bovine lens protein for 5 days at
37‡C, in 0.05 M phosphate bu¡er, pH 7.0.
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human sorbitol dehydrogenase [36]. We next eval-
uated the activity pro¢le over physiological ratios
of NAD/NADH known to exist in the lens [37].
As can be seen (Fig. 8, upper panel) even at the
most inhibitory ratio of NAD/NADH of 4:1 the
reductive activity was still V75% of that in the ab-
sence of NAD. The e¡ects of varying the ERU/D-
sorbitol ratio were more signi¢cant. At a ratio of
1:12 the activity was inhibited V50%, (Fig. 8, lower
panel).
Finally, we used 13C-NMR to study the reduction
of ERU by HLH. The homogenate slowly reduced
ERU to L-threitol (65.60 ppm) using only the
NADH present in the HLH (Fig. 9, upper panel).
As calculated from relative signal intensities of C1
of ERU and C1 of L-threitol, the breakdown of the
entire 2.5 Wmol of 2,3-DKG over 6 h (V7 nmol
min31), is met by a corresponding reduction rate of
V1.1 nmol min31 and a total of V400 nmol of L-
threitol. At 14 h, V600 nmol of L-threitol were pro-
duced. Since human lens contains only 51^210 nmol
of NADH [37], the reduction rate is clearly limited
by the availability of endogenous NADH, and the
recycling of NAD to NADH. However, in the pres-
ence of excess of 5.0 Wmol added NADH, the tre-
mendous capacity of the lens to reduce the 2.5 Wmol
of ERU produced from 2,3-DKG is apparent (Fig. 9,
lower panel). Even at a £ux rate equivalent to the
turnover of the entire physiological level of 2.5 Wmol
of AsA in only 4 h, little ERU can be detected and
the C3 resonance of 2,3-DKG is converted to the C1
of L-threitol rapidly.
4. Discussion
ERU is the major product of the non-oxidative
degradation of DHA, and 2,3-DKG. To our knowl-
edge, this ketose product, which is formed in v 97%
yield from 2,3-DKG, has not been previously re-
ported. The in vitro degradation of AsA has been
studied extensively under a variety of conditions to
determine the fate of AsA oxidation products, both
in solution, and in tissue homogenates. From these
previous studies, an astounding variety of degrada-
tion/catabolic products of vitamin C have been re-
ported. The conditions of these studies were primar-
ily oxidative, owing to the need to initially oxidize
AsA with O2 to initiate the subsequent degradation.
The reaction of H2O2, (the ignored product of AsA
oxidation to DHA), with DHA and 2,3-DKG during
their degradative fates has not been generally consid-
ered. Since many of the studies on the degradation
and catabolism of AsA have been carried out in
bu¡ers containing Fe3 and Cu2 impurities [38],
hydroxyl radical would be generated in signi¢cant
amounts from the H2O2 product by the Fenton re-
action [39]. It has been determined that H2O2 and
DHA react directly at pH 7 to produce L-threonate
and oxalate [40] quantitatively. Importantly, these
products are among the reported catabolic metabo-
lites of AsA [17,19]. It is essential to emphasize that
no L-threonate can be produced from DHA or 2,3-
DKG without their oxidation. In addition, it is well
established that H2O2 reacts with 2-keto aldonic
acids such as 2,3-DKG with sequential decarboxyla-
Fig. 8. Determination of human lens homogenate reductive ac-
tivity towards ERU. Upper panel shows enzyme activity with
increasing NAD. Lower panel shows enzyme activity with in-
creasing D-sorbitol. Each point was done in duplicate, with no
variations s 0.005 for any assay.
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tion of C1 and C2 [41]. This oxidation could account
for the numerous reports of CO2, and the ¢ve carbon
or four carbon sugar acid products seen in ascorbate
degradations. The known e¡ect of hydroxyl radical
production on sugars is to cause oxidative fragmen-
tation [41], with production of a variety of products,
which may also have been erroneously reported as
AsA catabolic products.
Our results support the hypothesis that two major
AsA degradation pathways exist at physiological pH,
Fig. 9. 13C-NMR following the reduction of ERU to L-threitol by human lens homogenate. Upper panel shows the degradation of
2.5 mM L-[3-13C]2,3-DKG to L-[1-13C]ERU, with subsequent reduction to L-[1-13C]threitol. Lower panel shows the same conditions
with 5.0 mM NADH added. Spectra were taken sequentially, with 5760 scans per spectrum. Data points are the average change over
4 h (or 2 h), from 4 to 8 h or (or 6 h), from 8 to 12 h (or 10 h) and from 12 to 16 h (or 14 h).
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one oxidative, and the second non-oxidative (see
Scheme 1). Central to the determination of which
pathway predominates is the oxidative status of the
milieu during 2,3-DKG degradation. In the presence
of high concentrations of H2O2, 2,3-DKG produces
L-threonate, oxalate, and CO2. In the absence of
H2O2, s 97% ERU and oxalate are produced. The
autoxidation of AsA in the absence of metal ions to
L-threonolactone and oxalate has been recently re-
ported by Miyake et al. This new pathway proceeds
independent of DHA, but concomitant with the
DHA-dependent pathway. Though potentially im-
portant, DHA was still the major product (s 85%)
even during AsA autoxidation to L-threonolactone
and oxalate [42].
Only a few studies have been done on the non-
oxidative degradation of AsA at physiological con-
ditions. In two such studies, ERU has been previ-
ously detected, but misidenti¢ed. Kang et al. [17]
assessed the 13C-NMR spectrum of the major DHA
degradation product as L-xylosone (a 5-carbon prod-
uct), when it clearly shows both ERU and oxalate.
Also their spectrum does not correspond to the pub-
lished spectra of L-xylosone [27]. Lopez and Feather
[21] detected a tetrose produced in high yield in AsA,
DHA and 2,3-DKG degradations. However, they
misidenti¢ed it as L-threose, using a TLC solvent
system, which did not adequately separate erythru-
lose and threose (see Table 1, irrigant B).
Although none of our incubations were under
strictly anaerobic conditions, our determination of
the non-oxidative degradation pathway of AsA was
dependent on several factors. First, the use of DHA
and 2,3-DKG eliminated production of H2O2 during
the obligatory oxidation of AsA. Additionally, in
each case, dissolved O2 was insigni¢cant (V0.2
mM), because the concentration of DHA, or 2,3-
DKG (0.1^0.2 M) were three orders of magnitude
of greater than O2. We used ascorbate oxidase
when con¢rming ERU production from AsA, which
prevented the production of H2O2 during the oxida-
tion of ascorbate (the products of ascorbate oxidase
are H2O and DHA). The use of chelex-treated
bu¡ers reduced participation of the Fenton reaction
in the studied degradation pathway. These condi-
tions more closely re£ect those in vivo under which
DHA and 2,3-DKG would degrade, namely in an
environment with no free metals, and in low levels
of H2O2 due to its rapid endogenous detoxi¢cation
by the antioxidant enzymes catalase and glutathione
peroxidase. However although we do not know
which pathway operates in vivo, the discovery of
the non-oxidative pathway and its novel product
ERU is signi¢cant, and may be important to the ¢nal
determination of AsA catabolism.
We have shown that the major non-oxidative deg-
radation product of AsA under physiological condi-
tions is ERU. The ketose should be very reactive
towards protein amino groups, since (by NMR)
ERU appears in solution to exist nearly 100% in
the free carbonyl form. Sugar reactivity towards pro-
tein amino groups has been strongly correlated with
the percentage of free carbonyl of a particular mono-
saccharide in solution [43,44]. Therefore, ERU is im-
plicated as the species responsible for the faster and
greater extent of protein crosslinking seen in incuba-
tions of AsA and protein, compared to similar incu-
bations to those with using glucose [5]. The proba-
bility that ERU mediates AsA-dependent cross-
linking is also argued by the relative half-lives of
the AsA degradation products under conditions sim-
ilar to those used in protein crosslinking studies (see
Figs. 2 and 3). With a half-life of V32 h in phos-
Scheme 1.
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phate ERU based on structural considerations,
should also be much more reactive than the short-
lived DHA or 2,3-DKG with protein nucleophiles.
This is especially true since DHA and 2,3-DKG are
predominantly in unreactive hydrated and cyclic
forms in solution. In addition to protein crosslinking,
ERU produces more O32 upon glycation than other
proposed glycators [45], which would increase its po-
tential toxicity.
ERU may be a previously unidenti¢ed catabolite
of AsA in vivo. We have determined that human lens
has substantial NADH-dependent sorbitol dehydro-
genase reductive activity for this ketose producing,
NAD and L-threitol. The kinetics of ERU reduc-
tion, production of the product L-threitol, and the
inhibition of reduction by D-sorbitol support both
the identi¢cation of the reductive activity as that of
lens sorbitol dehydrogenase, and further verify the
product of 2,3-DKG degradation as ERU. We
have shown that given a supply of NADH human
lens has the capacity to prevent the accumulation of
ERU, even at rapid rates of 2,3-DKG degradation.
Therefore ERU may be the progenitor of lens L-
threitol, a metabolite whose origin is still unknown
[46], and may originate from AsA catabolism. Addi-
tionally, a role for sorbitol dehydrogenase in reduc-
tion and detoxi¢cation of ERU could associate in-
creased AsA oxidation and catabolism with the
complications resulting from altered sorbitol path-
way function. The fate of lenticular threitol is un-
known; however, increased polyol production has
been strongly implicated in cataract formation and
diabetic complications.
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